Boston Scientific Corporation Share Price
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.27 USD | +6.81% |
|
+4.57% | -41.47% |
| 08:04pm | Boston Scientific Makes Third Attempt at TAVR Market, Needham Says | MT |
| 03:23pm | Global markets live: Merck, Regeneron, Ford, Lululemon, Brambles… |
| Capitalization | 78.3B 67.28B 61.55B 58.46B 108B 7,543B 109B 737B 286B 3,569B 294B 288B 12,440B | P/E ratio 2026 * |
19.4x | P/E ratio 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise value | 84.6B 72.68B 66.5B 63.16B 116B 8,149B 118B 796B 308B 3,856B 317B 311B 13,440B | EV / Sales 2026 * |
3.9x | EV / Sales 2027 * | 3.44x |
| Free-Float |
84.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +6.81% | ||
| 1 week | +4.57% | ||
| Current month | -3.12% | ||
| 1 month | -8.49% | ||
| 3 months | -26.84% | ||
| 6 months | -43.75% | ||
| Current year | -41.47% |
| 1 week | 52.52 | 55.86 | |
| 1 month | 52.52 | 66.88 | |
| Current year | 52.52 | 100.9 | |
| 1 year | 52.52 | 109.5 | |
| 3 years | 48.35 | 109.5 | |
| 5 years | 34.98 | 109.5 | |
| 10 years | 19.67 | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
John Sorenson
COO | Chief Operating Officer | 58 | 30/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.85% | +4.57% | -47.67% | +4.43% | 78.3B | ||
| +0.82% | -2.66% | +6.44% | -15.85% | 163B | ||
| +4.52% | +4.52% | -21.82% | +40.62% | 149B | ||
| +1.25% | -1.60% | -16.58% | -27.64% | 115B | ||
| +1.27% | +6.54% | +5.36% | -5.94% | 46.86B | ||
| +0.78% | +0.27% | -31.61% | -36.54% | 43.31B | ||
| +1.13% | -4.50% | -7.29% | +24.01% | 32.32B | ||
| +0.56% | +0.57% | -1.18% | -13.19% | 31.57B | ||
| +1.77% | +3.07% | -19.14% | -8.63% | 29.28B | ||
| -2.52% | -8.37% | -30.93% | -49.50% | 28.5B | ||
| Average | +1.67% | -3.79% | -16.44% | -8.82% | 71.68B | |
| Weighted average by Cap. | +2.27% | -4.50% | -14.89% | -3.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.68B 18.63B 17.04B 16.19B 29.8B 2,089B 30.31B 204B 79.06B 988B 81.36B 79.64B 3,444B | 23.62B 20.29B 18.57B 17.63B 32.47B 2,275B 33.02B 222B 86.13B 1,077B 88.64B 86.76B 3,752B |
| Net income | 3.96B 3.4B 3.11B 2.96B 5.44B 381B 5.53B 37.24B 14.43B 180B 14.85B 14.54B 629B | 4.18B 3.59B 3.28B 3.12B 5.74B 402B 5.84B 39.31B 15.23B 190B 15.68B 15.35B 664B |
| Net Debt | 6.29B 5.41B 4.95B 4.7B 8.65B 606B 8.8B 59.22B 22.95B 287B 23.62B 23.12B 1T | 2.9B 2.49B 2.28B 2.16B 3.99B 279B 4.05B 27.28B 10.57B 132B 10.88B 10.65B 461B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/05/26 | 55.86 $ | +6.04% | 9,270,844 |
| 15/05/26 | 52.68 $ | -1.62% | 14,843,339 |
| 14/05/26 | 53.55 $ | +0.92% | 14,595,126 |
| 13/05/26 | 53.06 $ | -1.92% | 17,994,229 |
| 12/05/26 | 54.10 $ | +1.37% | 15,917,843 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















